Literature DB >> 17176918

Acute immuno-allergic interstitial nephritis caused by fluindione.

S Belmouaz1, E Desport, R Abou Ayache, A Thierry, A Mignot, M Bauwens, J M Goujon, F Bridoux, G Touchard.   

Abstract

Fluindione is a vitamin K antagonist that is commonly prescribed for the treatment of cardiovascular disease and venous thromboembolism in France. Bleeding is the most common side effect of fluindione, whereas hypersensitivity reactions are rare. We describe here a patient with acute immuno-allergic interstitial nephritis caused by fluindione. Initial symptoms included fever, eosinophilia, low albuminuria, microscopic hematuria, eosinophiluria and acute renal failure. Kidney biopsy showed severe interstitial nephritis with interstitial edema, inflammatory infiltrates and tubulorrhexis. Fluindione withdrawal and corticosteroid treatment resulted in rapid recovery of renal function. A review of the literature revealed a very low incidence of fluindione-induced interstitial nephritis, with variable renal and extra-renal signs. Early recognition of this rare complication may prevent the development of severe chronic renal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176918     DOI: 10.5414/cnp66455

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?

Authors:  Amélie Daveluy; Brigitte Milpied; Annick Barbaud; Bénédicte Lebrun-Vignes; Aurore Gouraud; Marie-Laure Laroche; Ecaterina Ciobanu; Bernard Bégaud; Nicholas Moore; Ghada Miremont-Salamé; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2011-07-27       Impact factor: 2.953

2.  Fluindione-induced immuno-allergic interstitial nephritis.

Authors:  Rania Kheder-Elfekih; Caroline Poitou; Isabelle Brocheriou; Helene Depreneuf; Hassane Izzedine
Journal:  NDT Plus       Date:  2008-11-21

3.  'Prevention is better than cure': warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury.

Authors:  Julie Belliere; Ben Sprangers
Journal:  Clin Kidney J       Date:  2022-06-22

4.  Reversible Fluindione-Induced Chronic Interstitial Nephritis.

Authors:  Thomas Crepin; Jamal Bamoulid; Cécile Courivaud; Omar Dahmani; Sophie Felix; Didier Ducloux
Journal:  Case Rep Nephrol       Date:  2016-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.